Takeda

We follow the science, to unlock innovation and pursue sustainable answers. We are guided by our commitment to patients, our people and the planet. Our vision is to deliver life-transforming treatments to those in need. We are steadfast in our purpose for better health for people and a brighter future for the world.

We are delighted to announce the successful topping-off ceremony for our new R&D site in Vienna, Austria. In the company of esteemed representatives from government, business, academia, and many Takeda colleagues, we celebrated this significant milestone in the construction of our “Lab of the Future.” This cutting-edge, environmentally sustainable facility will enable our scientists to develop groundbreaking therapies for diseases with high unmet needs, utilizing the latest technologies and innovative systems. Learn more about this exciting project: https://lnkd.in/ed8uu6SG #Labofthefuture #sustainability #Innovation

We leave #ACR24 inspired, having shared multiple abstracts detailing recent data in #PsoriaticArthritis while connecting with other researchers who share a common goal: to find better options for people living with this condition. American College of Rheumatology

What does paper have to do with creating better health for people and a brighter future for the world? More than you might think. Read about how we exceeded our recycled packaging goal by 3% and 2 years: https://lnkd.in/dNmJTwtQ #OurStories

Holidays are meant to be a time of joy and togetherness—but for people with celiac disease, communal meals can lead to anxious feelings around accidental gluten exposure. The National Celiac Association offers helpful tips to ensure those with celiac disease can safely enjoy holiday gatherings: https://lnkd.in/e5gDqptc 

Recently, Giles Platford, Chair of the Global Executive Board for the Plasma Protein Therapeutics Association (PPTA) spoke at POLITICO Europe’s 2024 Health Care Summit on the need for flexible approaches and inclusive dialogue to secure supply of essential medicines in Europe. Watch here: https://bit.ly/4fCMRaE #plasma #plasmadonation #raredisease #PoliticoHealthcare

We are excited to join #ICID (the 2024 International Congress on Infectious Diseases) Congress again this year! Visit booths #17 & #26 to learn about exciting new developments in dengue research. Booths initiated and funded by Takeda. #ICID2024 #MedicalCongress #DengueResearch #HealthcareInnovation #ISIDCongress2024 #dengue

We leave The Liver Meeting inspired by the rich dialogue, emerging data and interest in alpha-1 antitrypsin deficiency-associated liver disease. Thank you to the American Association for the Study of Liver Diseases (AASLD) for bringing together some of the brightest minds in the hepatology community to strengthen our collective knowledge and forge connections that can help enhance patient care in areas like Alpha-1 #LiverDisease. #tlm24

Did you know alpha-1 antitrypsin deficiency (AATD) can manifest as liver disease independently or in combination with lung disease? Since many people with AATD-associated chronic liver disease do not have symptoms, the condition is underdiagnosed and often misunderstood. This #Alpha1Awareness Month, we’re leveraging our power to connect to help shape the future of care for people living with this progressive genetic condition. Watch to learn more.

Our Plasma-Derived Therapies (PDT) team is dedicated to transforming the lives of patients worldwide who rely on life-transforming and life-sustaining plasma-based therapies. And our commitment to patients starts with our commitment to the well-being of our employees and their families. Christopher Tremblay, PDT R&D Operations, reflects on programs like Thrive that help employees feel a sense of engagement and belonging. Join a team that prioritizes employee health, well-being and resilience. Explore jobs on our Plasma-Derived Therapies (PDT) team: https://lnkd.in/edrGTCBD